Astellas Pharma
4503.T
#623
Rank
$28.31 B
Marketcap
$15.50
Share price
-0.40%
Change (1 day)
-0.90%
Change (1 year)

Revenue for Astellas Pharma (4503.T)

Revenue in 2022 (TTM): $10.87 B

According to Astellas Pharma's latest financial reports the company's current revenue (TTM) is $10.87 B. In 2021 the company made a revenue of $11.61 B a decrease over the years 2020 revenue that were of $11.81 B.The revenue is the total amount of income that a company generates by the sale of goods or services. Unlike with the earnings no expenses are subtracted.

Revenue history for Astellas Pharma from 2009 to 2022

Annual revenue

Year Revenue Change
2022 (TTM)$10.87 B-6.35%
2021$11.61 B-1.71%
2020$11.81 B-0.12%
2019$11.83 B-0.07%
2018$11.84 B1.85%
2017$11.62 B-4.31%
2016$12.15 B7.88%
2015$11.26 B1.48%
2014$11.09 B-3.1%
2013$11.45 B-2.61%
2012$11.76 B-5.31%
2011$12.42 B14.28%
2010$10.86 B4.53%
2009$10.39 B